IN2014KN01037A - - Google Patents

Info

Publication number
IN2014KN01037A
IN2014KN01037A IN1037KON2014A IN2014KN01037A IN 2014KN01037 A IN2014KN01037 A IN 2014KN01037A IN 1037KON2014 A IN1037KON2014 A IN 1037KON2014A IN 2014KN01037 A IN2014KN01037 A IN 2014KN01037A
Authority
IN
India
Prior art keywords
glutamine
diabetes
compositions
treatment
body weight
Prior art date
Application number
Other languages
English (en)
Inventor
Yutaka Niihara
Original Assignee
Emmaus Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48470183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014KN01037(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emmaus Medical Inc filed Critical Emmaus Medical Inc
Publication of IN2014KN01037A publication Critical patent/IN2014KN01037A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN1037KON2014 2011-11-21 2012-11-17 IN2014KN01037A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161629633P 2011-11-21 2011-11-21
PCT/US2012/000557 WO2013077893A1 (en) 2011-11-21 2012-11-17 Methods and compositions for the treatment of diabetes and related symptoms

Publications (1)

Publication Number Publication Date
IN2014KN01037A true IN2014KN01037A (enExample) 2015-10-09

Family

ID=48470183

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1037KON2014 IN2014KN01037A (enExample) 2011-11-21 2012-11-17

Country Status (10)

Country Link
US (2) US20130143968A1 (enExample)
EP (2) EP2782588B1 (enExample)
JP (4) JP6089042B2 (enExample)
CN (3) CN103945858A (enExample)
BR (1) BR112014011898A2 (enExample)
ES (1) ES2785094T3 (enExample)
HK (1) HK1257401A1 (enExample)
IN (1) IN2014KN01037A (enExample)
PH (2) PH12020550726B1 (enExample)
WO (1) WO2013077893A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
WO2003072556A1 (en) * 2001-06-27 2003-09-04 Prosidion Ltd. Glutaminyl based dpiv inhibitors
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
US20070025953A1 (en) * 2005-07-27 2007-02-01 Jones Michael R Co-therapy for diabetic conditions
CA2774197A1 (en) * 2006-04-22 2008-04-03 Harbor Biosciences, Inc. Drugs and uses to modulate inflammation, metabolic disorders and other conditions
WO2008038771A1 (en) * 2006-09-29 2008-04-03 Ajinomoto Co., Inc. Glutamine-containing composition for increasing blood flow
US20080221074A1 (en) * 2006-11-17 2008-09-11 Jaime Flores-Riveros Drug Screen and Treatment Method
EP2057905A1 (en) * 2007-11-12 2009-05-13 TIMA Foundation Composition for moderating Triglyceride and Cholesterol Levels
HUE034551T2 (en) * 2009-01-12 2018-02-28 Biokier Inc Composition and method for treatment of diabetes
NL1036746C2 (nl) * 2009-03-20 2010-09-21 Glnp Holding B.V. Kit van onderdelen bevattende l-glutamine en egcg.
MX2012003459A (es) * 2009-09-23 2012-05-22 Biokier Inc Composicion y metodo para el tratamiento de la diabetes.

Also Published As

Publication number Publication date
CN103945858A (zh) 2014-07-23
HK1257401A1 (zh) 2019-10-18
EP2782588A1 (en) 2014-10-01
JP6389495B2 (ja) 2018-09-12
BR112014011898A2 (pt) 2017-05-16
JP2014533689A (ja) 2014-12-15
JP6089042B2 (ja) 2017-03-01
PH12020550726A1 (en) 2021-06-14
US20190192463A1 (en) 2019-06-27
EP3437649A1 (en) 2019-02-06
PH12014501052B1 (en) 2020-10-09
PH12014501052A1 (en) 2014-06-30
JP2018199692A (ja) 2018-12-20
JP6550160B2 (ja) 2019-07-24
CN108354916A (zh) 2018-08-03
EP2782588A4 (en) 2015-05-20
PH12020550726B1 (en) 2022-11-09
ES2785094T3 (es) 2020-10-05
US20130143968A1 (en) 2013-06-06
CN108478551A (zh) 2018-09-04
JP2018115175A (ja) 2018-07-26
JP2017052766A (ja) 2017-03-16
EP2782588B1 (en) 2020-04-15
WO2013077893A1 (en) 2013-05-30

Similar Documents

Publication Publication Date Title
UA114726C2 (uk) 1,4-дизаміщені аналоги піридазину та способи лікування пов'язаних з дефіцитом smn станів
WO2010080756A3 (en) Harmine derivatives for reducing body weight
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
MX349159B (es) Derivados deuterados de ivacaftor.
MY173877A (en) Branched 3-phenylpropionic acid derivatives and the use thereof
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
IN2014CN00562A (enExample)
MX2013011691A (es) Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MX360634B (es) Inhibidores de 3-haloalilamina sustituidos de ssao y uso de los mismos.
MY170802A (en) Treatment of pulmonary disease
MX2015007916A (es) Peri-carbinoles.
UA110983C2 (uk) Похідна 1,2,3,4-тетрагідрохіноліну, придатна для лікування діабету
SG10201810401RA (en) Pharmaceutical combinations for treating cancer
MX2015009444A (es) Trampas novedosas en el tratamiento de la degeneracion macular.
IN2015DN01151A (enExample)
EA030383B9 (ru) Бициклически замещённые урацилы, способы их получения, их применение, лекарственное средство и способ лечения с их применением
PH12015502302A1 (en) Treatment of allergic rhinitis using a combination of mometasone and olopatadine
SG10201900541QA (en) Derivatives of xanthone compounds
FI20115165A0 (fi) Terapeuttisia ja diagnostisia menetelmiä
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
IN2014KN01255A (enExample)
PH12020550726A1 (en) Method and compositions for the treatment of diabetes and related symptoms
NZ707773A (en) Methods of treating liver diseases
IN2014DN08443A (enExample)
IN2014CN02315A (enExample)